875 studies found for:    "Hepatitis C, Chronic"
Show Display Options
Rank Status Study
21 Terminated Efficacy and Safety of Pentoxyphilline and Tocopherol on the Fibrosis in Patients With Chronic Hepatitis C
Conditions: Hepatitis C, Chronic;   Liver Fibrosis
Interventions: Drug: pentoxyphilline;   Drug: tocopherol
22 Terminated Viral Kinetic Study With Viramidine in Therapy-Naive Patients With Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Interventions: Drug: Viramidine;   Drug: Peginterferon alfa-2b
23 Active, not recruiting Prospective Observational Study of Disease Progression in Chronic Hepatitis C
Conditions: Hepatitis C, Chronic;   Disease Progression;   Liver Cirrhosis
Intervention:
24 Completed A Study of Combination Treatment With Pegasys (Peginterferon Alfa) and Copegus (Ribavirin)in Patients With Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Interventions: Drug: Copegus (ribavirin);   Drug: peginterferon alfa-2a [Pegasys]
25 Recruiting An Observational Study on Dual And Triple Therapies Based on Peginterferon Alfa (e.g. Pegasys) in Patients With Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Intervention:
26 Completed A Study of Ribavirin in Combination With PEGASYS (Peginterferon Alfa-2a (40KD))in Patients With Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Interventions: Drug: peginterferon alfa-2a [Pegasys];   Drug: ribavirin
27 Completed A Study on the Correlation Between Interleukin 28B Genotypes With Clinical and Demographic Characteristics in Treatment-Naïve and Treatment-Experienced Patients With Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Intervention: Other: Interleukin 28B testing
28 Completed Antiviral Efficacy, Pharmacokinetics and Safety of BILN 2061 ZW in Patients With Cirrhosis and Chronic Hepatitis C
Conditions: Liver Cirrhosis;   Hepatitis C, Chronic
Interventions: Drug: BILN 2061 ZW;   Drug: Placebo
29 Completed
Has Results
Patient Compliance During PegIntron and Rebetol Combination Therapy in Chronic Hepatitis C (Study P04690)
Conditions: Hepatitis C, Chronic;   Hepatitis C
Interventions: Biological: PegIntron (Peginterferon alfa-2b);   Drug: Rebetol (Ribavirin)
30 Completed
Has Results
Treatment of Patients With Chronic Hepatitis C With PegIntron as Monotherapy or in Combination With Ribavirin (Study P04437)(COMPLETED)
Conditions: Hepatitis C, Chronic;   Hepacivirus
Interventions: Biological: Peginterferon alfa-2b (SCH 54031);   Drug: Ribavirin (SCH 18908)
31 Completed A Retrospective Study of Real World Treatment Outcomes of Patients With Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Intervention:
32 Completed A Triple Combination Therapy Study of Boceprevir, Pegasys and Copegus in Previously Untreated Patients With Genotype 1 Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Interventions: Drug: boceprevir;   Drug: peginterferon alfa-2a [Pegasys];   Drug: ribavirin (Copegus]
33 Not yet recruiting Randomized Study for the Assessment of Silibinin (Legalon® SIL) in the Treatment of naïve Genotype 4 Patients With Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Interventions: Drug: Legalon® SIL (Silibinin);   Drug: Pegylated interferon alfa2b;   Drug: Ribavirin
34 Completed Effect of Low-dose PegIntron on ALT Normalization in Japanese Patients With Chronic Hepatitis C (Study P04508)(COMPLETED)
Conditions: Hepatitis C, Chronic;   Hepatitis C
Intervention: Biological: PegIntron (peginterferon alfa-2b)
35 Completed
Has Results
Study of PEG-Intron Plus REBETOL in Pediatric Subjects With Chronic Hepatitis C (Study P02538 Part 1)
Condition: Hepatitis C, Chronic
Interventions: Biological: peginterferon alfa-2b (PEG2b) (SCH 54031);   Drug: ribavirin (SCH 18908)
36 Completed Long-Term Evaluation Follow-up of Neurocognitive Performance and Emotional State in Patients With Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Intervention:
37 Completed A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Ribavirin in Hemophiliac Patients With Chronic Hepatitis C.
Condition: Hepatitis C, Chronic
Interventions: Drug: peginterferon alfa-2a [Pegasys];   Drug: ribavirin
38 Terminated
Has Results
Efficacy of Peginterferon Alfa-2b (SCH 054031) vs Glycyrrhizin in Interferon (IFN)-Treated Patients With Chronic Hepatitis C and F2/F3 Liver Fibrosis (P04773)
Condition: Hepatitis C, Chronic
Interventions: Biological: Peginterferon alfa-2b (PegIFN-2b);   Drug: Comparator: Stronger neo minophagen C (SNMC)
39 Active, not recruiting An Observational Study of Dual and Triple Therapies Based on Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Intervention:
40 Completed A Study of Danoprevir/Ritonavir and Copegus With RO5024048 and/or Pegasys in Patients With Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Interventions: Drug: Copegus;   Drug: Pegasys;   Drug: RO5024048;   Drug: danoprevir;   Drug: ritonavir

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years